1,1,2,2-Tetrakis(4-(1H-pyrazol-4-yl)phenyl)ethene, 100mg

4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine, 95.0%, 50mg

1-(2,6-Dichloro-3-fluorophenyl)ethanol, 95.0%, 1g

1H-Indazol-5-amine, 97.0%, 1g

Methyl 2,3-diamino-6-methylbenzoate, 98%, 1g

Ethyl (2-chloro-5-thenoyl)acetate, 95.0%, 5g

2-chloro-N-phenylpropanamide, 95.0%, 1g

5-Bromo-2,4-dimethoxypyrimidine>98.0%(GC)25g

3-Bromo-2-fluorobenzoic acid, 98.0%, 5g

GC-Kapillarsäule ROTI®Cap-FFAP, polar, L 30 m, Ø-Innen 0,32 mm, Filmd. 0,50 µm, 1 Stück

2-Amino-5-bromo-4-methylthiazole, 95.0%, 1g

2-(1-methoxycyclopropyl)ethan-1-amine hydrochloride, 95.0%, 10g

(S)-tert-Butyl 3-(bromomethyl)piperidine-1-carboxylate, 95.0%, 1g